Trial intelligence / Profile preview

Outpatient IV Ketamine for CRPS

NCT00579085Phase 2Completed

Sponsor
Drexel University
Start
Sep 2006
Primary completion
Sep 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in complex regional pain syndrome (CRPS) comparing Ketamine with Placebo (2 arms). Primary endpoint: 30% pain reduction post treatment at 3 months. Started Sep 2006; status: completed.

02

Drugs

ketamine
03

Conditions

complex regional pain syndrome (CRPS)

Beyond the preview

Go deeper on NCT00579085.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00579085.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call